| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |